← SynDRA
N-Ethyldicyclohexylamine
SynDRA canonical compound SYN1978582 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HP | TJP1 |
|---|
| Mechanism of action | tight junction regulator |
|---|
All known targets
Mechanisms of action (all sources)
- CHRNB4 PARTIAL AGONIST
- Neuronal acetylcholine receptor; alpha3/beta4 partial agonist
- CHRNA3 PARTIAL AGONIST
- tight junction regulator
- HP MODULATOR
Cross-references
Synonyms
- N-Cyclohexyl-N-ethylcyclohexanamine
- Ethyldicyclohexylamine
- dicyclohexylethylamine
- Cyclohexanamine, N-cyclohexyl-N-ethyl-
- DICYCLOHEXYLAMINE, N-ETHYL-
- EINECS 230-534-1
- NSC-221147
- BRN 2240256
- 9A5D20NJX6
- UNII-9A5D20NJX6
- 4-12-00-00024 (Beilstein Handbook Reference)
- RefChem:163345
- DTXCID5047112
- XRKQMIFKHDXFNQ-UHFFFAOYSA-N
- N-Cyclohexyl-N-ethylcyclohexylamine
- MFCD00003846
- NSC221147
- ethyl-dicyclohexylamine
- SCHEMBL23038
- SCHEMBL736427
- N-Ethyldicyclohexylamine, 96%
- SCHEMBL1582319
- SBB060235
- N-Cyclohexyl-N-ethylcyclohexanamine #
- AKOS016014071
- DB-055565
- NS00037285
- ST50405277
- Larazotide Acetate
- Larazotide [INN]
- NYGCNONRVCGHAT-UFIKZEAMSA-N
- Larazotida
- AT-1001
- D09351
- SCHEMBL23668120
- Glycine, glycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolyl-, monoacetate
- H-Gly-Gly-DL-Val-DL-Leu-DL-Val-DL-Gln-DL-Pro-Gly-OH
- orb1308139
- RefChem:798506
Look up N-Ethyldicyclohexylamine in the interactive SynDRA portal →